Conditional deletion of Crebpp or Kmt2d in mouse B cells results in GC hyperplasia and increases the incidence of GC lymphoma in BCL2-driven mouse models after iterative SRBC immunization, with a spectrum of histopathological features ranging from early FL to DLBCL (80–84). This evidence concerns the gene BCL2 and lymphoma.